For outpatient imaging centers, ensuring patient safety during contrast-enhanced procedures is paramount. Given the potential for severe allergic reactions to iodinated contrast media, every facility must be equipped with epinephrine to manage anaphylaxis effectively. Epinephrine is the first-line treatment for anaphylaxis. No other medication stops the life-threatening effects of anaphylaxis.
Allergic contrast reactions are rare (0.2–0.6% of all injections) and can range from mild rashes to life-threatening anaphylaxis.1,2 Although the vast majority of these are self-limited, delayed epinephrine administration can be fatal in cases of severe reactions.
Epinephrine typically takes effect within three to five minutes, with intramuscular injection into the anterolateral thigh being the preferred route.3 In outpatient settings, epinephrine auto-injectors offer a practical advantage, allowing for faster administration and reducing the risk of dosing errors.4 When used at recommended doses, epinephrine is highly safe, with common side effects including agitation, anxiety, tremors, or headache. There are no absolute contraindications for its use in anaphylaxis. Because the progression of an allergic reaction is unpredictable, early administration should be strongly considered, even for mild symptoms or single-system involvement.4
Intramuscular Epinephrine: The Foundation of a Smart Contrast Reaction Protocol
Intramuscular (IM) administration of epinephrine for anaphylaxis is the preferred route due to its proven safety profile and ease of use, as endorsed by multiple international guidelines.4–7 IM injection is widely recognized as a safe and effective method in both clinical and non-clinical settings—even school teachers have been successfully trained to administer it.8,9 While the American College of Radiology’s Manual on Contrast Media now requires only IM epinephrine as part of its minimum equipment standards.10
Why Protocolization Matters
In high-stakes environments, from aviation to surgery, checklists and standardized protocols are essential in preventing errors and improving outcomes. The same applies to contrast reaction management—having a clear, step-by-step process eliminates guesswork and reduces the risk of critical mistakes.
Without standardized protocols and education, providers can struggle with epinephrine administration. Studies have shown that in the absence of structured guidelines, errors occur such as
- Administering IV epinephrine instead of IM.
- Failing to administer epinephrine at all.11,12
These mistakes delay life-saving treatment and increase risks for patients. However, a simple, well-designed protocol—complete with checklists and auto-injectors—ensures that every provider can act confidently and correctly in an emergency.
Benefits of Auto-Injectors
Compared to manual epinephrine administration, auto-injectors offer several advantages:
1. Faster Administration
- A study comparing manual injection vs. auto-injector in a simulated contrast reaction found that auto-injectors cut administration time by more than half (38.7 vs. 108.8 seconds)13
- In an emergency, every second counts—delays in administration increase the risk of fatality.
2. Reduced Risk of Dosing Errors
- Epinephrine auto-injectors come preloaded with a fixed dose, eliminating the risk of drawing up the wrong amount.
- Manual injections require calculating and measuring doses, leaving room for human error—especially under stress.
3. Easier for Non-Physician Staff to Use
- Auto-injectors require fewer steps and provide step-by-step instructions during use.
- This makes it easier for nurses, technologists, or administrative staff to administer the injection correctly.
Outpatient imaging centers should be aware of various epinephrine delivery options in case of contrast-related anaphylaxis. The EpiPen is the most widely recognized auto-injector, while Auvi-Q offers voice-guided instructions and a retractable needle for added safety. Adrenaclick provides a lower-cost alternative but requires slightly different administration steps, and Neffy, a new needle-free nasal spray, may be preferred by patients with needle aversion. Symjepi and Epinephrine Snap Kit require manual injection and are generally lower-cost but demand more training and confidence in administration.
Final Recommendation
For most outpatient imaging centers performing contrast studies, epinephrine auto-injectors are the safest, most effective option with a proven track record. Given the potential for anaphylaxis, quick, error-free administration is essential.
At our organization, we prefer to work with centers that stock auto-injectors to ensure:
- Faster administration.
- Fewer medical errors.
- Increased staff confidence.
- Better patient outcomes.
Make the right choice for your imaging center.
---
References:
1. Wang CL, Cohan RH, Ellis JH, Caoili EM, Wang G, Francis IR. Frequency, Outcome, and Appropriateness of Treatment of Nonionic Iodinated Contrast Media Reactions. Am J Roentgenol. 2008;191(2):409-415. doi:10.2214/AJR.07.3421
2. Cochran ST, Bomyea K, Sayre JW. Trends in Adverse Events After IV Administration of Contrast Media. Am J Roentgenol. 2001;176(6):1385-1388. doi:10.2214/ajr.176.6.1761385
3. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045. doi:10.1111/all.12437
4. Simons FER, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8:32. doi:10.1186/s40413-015-0080-1
5. Cardona V, Ansotegui IJ, Ebisawa M, et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organ J. 2020;13(10):100472. doi:10.1016/j.waojou.2020.100472
6. Pflipsen MC, Vega Colon KM. Anaphylaxis: Recognition and Management. Am Fam Physician. 2020;102(6):355-362.
7. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis—a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384. doi:10.1016/j.anai.2015.07.019
8. Donovan P, O’Connor P. The confidence and competence of primary school staff to administer an adrenaline auto-injector. Eur J Pediatr. Published online 2024:1-6.
9. Lejtman P, Hetroit-Vasseur E, Morello R, Vial S, Brouard J. Evaluation of a video training program’s impact on primary teachers’ knowledge of allergies and skills in using an adrenaline autoinjector during the 2021–2022 school year. Arch Pédiatrie. 2024;31(5):299-305. doi:10.1016/j.arcped.2024.03.003
10. ACR Manual on Contrast Media. Published online 2024. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf
11. Lightfoot CB, Abraham RJ, Mammen T, Abdolell M, Kapur S, Abraham RJ. Survey of Radiologists’ Knowledge Regarding the Management of Severe Contrast Material–induced Allergic Reactions. Radiology. 2009;251(3):691-696. doi:10.1148/radiol.2513081651
12. Nandwana SB, Walls DG, Torres WE. Radiology Department Preparedness for the Management of Severe Acute Iodinated Contrast Reactions: Do We Need to Change Our Approach? Am J Roentgenol. 2015;205(1):90-94. doi:10.2214/AJR.14.13884
13. Asch D, Pfeifer KE, Arango J, et al. JOURNAL CLUB: Benefit of Epinephrine Autoinjector for Treatment of Contrast Reactions: Comparison of Errors, Administration Times, and Provider Preferences. Am J Roentgenol. 2017;209(2):W363-W369. doi:10.2214/AJR.16.17111
.svg)
.png)
